SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001819790-21-000059
Filing Date
2021-12-03
Accepted
2021-12-03 18:56:58
Documents
1
Period of Report
2021-12-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_163857580594057.html 4  
1 FORM 4 wf-form4_163857580594057.xml 4 9609
  Complete submission text file 0001819790-21-000059.txt   10977
Mailing Address 202 CARNEGIE CENTER SUITE 109 PRINCETON NJ 08540
Business Address
Ackermann Michael (Reporting) CIK: 0001791249 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39614 | Film No.: 211471530

Mailing Address 15440 LAGUNA CANYON ROAD IRVINE CA 92618
Business Address 15440 LAGUNA CANYON ROAD IRVINE CA 92618 (949) 409-9820
Tarsus Pharmaceuticals, Inc. (Issuer) CIK: 0001819790 (see all company filings)

IRS No.: 814717861 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)